Strahlentherapie des Mediastinalen Hodgkin-Lymphoms

Literaturverzeichnis
8 LITERATURVERZEICHNIS
Adams, M.J., Hardenbergh, P.H., Constine, L.S., and Lipshultz, S.E. (2003). Radiation-associated cardiovascular
disease. Critical Reviews in Oncology/Hematology 45, 55-75.
Ahnesjö, A. (1989). Collapsed cone convolution of radiant energy for photon dose calculation in heterogeneous
media. Med Phys 16, 577-592.
Ahnesjö, A., and Aspradakis, M.M. (1999). Dose calculations for external photon beams in radiotherapy. Phys
Med Biol 44, R99-155.
Ahnesjö, A., Saxner, M., and Trepp, A. (1992). A pencil beam model for photon dose calculation. Med Phys 19,
263-273.
Alber, M., and Belka, C. (2006). A normal tissue dose response model of dynamic repair processes. Phys Med
Biol 51, 153-172.
Alber, M., and Nüsslin, F. (1999). An objective function for radiation treatment optimization based on local
biological measures. Phys Med Biol 44, 479-493.
Alber, M., and Nüsslin, F. (2002). [A concept for the optimization of clinical IMRT]. Z Med Phys 12, 109-113.
Alber, M., Thorwarth, D., Ganswindt, U., and Belka, C. (2009). Fluenzmodulierte Strahlentherapie (IMRT). In
Radioonkologie, Band 1 Grundlagen, M. Bamberg, M. Molls, and H. Sack, eds. (München Wien New York: W.
Zuckschwerdt Verlag), pp. 189-201.
Aleman, B.M., Raemaekers, J.M., Tirelli, U., Bortolus, R., van 't Veer, M.B., Lybeert, M.L., Keuning, J.J.,
Carde, P., Girinsky, T., van der Maazen, R.W., Tomsic, R., Vovk, M., van Hoof, A., Demeestere, G.,
Lugtenburg, P.J., Thomas, J., Schroyens, W., De Boeck, K., Baars, J.W., Kluin-Nelemans, J.C., Carrie, C.,
Aoudjhane, M., Bron, D., Eghbali, H., Smit, W.G., Meerwaldt, J.H., Hagenbeek, A., Pinna, A., and Henry-
Amar, M. (2003a). Involved-field radiotherapy for advanced Hodgkin's lymphoma. N Engl J Med 348, 2396-
2406.
Aleman, B.M., and van Leeuwen, F.E. (2007). Are we improving the long-term burden of Hodgkin's lymphoma
patients with modern treatment? Hematol Oncol Clin North Am 21, 961-975.
Aleman, B.M.P., van den Belt-Dusebout, A.W., De Bruin, M.L., van 't Veer, M.B., Baaijens, M.H.A., Boer,
J.P.d., Hart, A.A.M., Klokman, W.J., Kuenen, M.A., Ouwens, G.M., Bartelink, H., and van Leeuwen, F.E.
(2007). Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 109, 1878-1886.
Aleman, B.M.P., van den Belt-Dusebout, A.W., Klokman, W.J., van't Veer, M.B., Bartelink, H., and van
Leeuwen, F.E. (2003b). Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin's Disease. J Clin
Oncol 21, 3431-3439.
Alexander, F.E., McKinney, P.A., Williams, J., Ricketts, T.J., and Cartwright, R.A. (1991). Epidemiological
Evidence for the 'Two-Disease Hypothesis' in Hodgkin's Disease. Int J Epidemiol 20, 354-361.
Allemani, C., Sant, M., Angelis, R.D., Marcos-Gragera, R., and Coebergh, J.W. (2006). Hodgkin disease
survival in Europe and the U.S. Cancer 107, 352-360.
Allen, A.M., Czerminska, M., Janne, P.A., Sugarbaker, D.J., Bueno, R., Harris, J.R., Court, L., and Baldini, E.H.
(2006). Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat
Oncol Biol Phys 65, 640-645.
Alm El-Din, M.A., El-Badawy, S.A., and Taghian, A.G. (2008). Breast Cancer After Treatment of Hodgkin's
Lymphoma: General Review. Int J Radiat Oncol Biol Phys 72, 1291-1297.
Altekruse, S., Kosary, C., Krapcho, M., Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z,
Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, and Edwards, B.K.
(2010). SEER Cancer Statistics Review, 1975-2007, http://seer.cancer.gov/csr/1975_2007/. National Cancer
Institute. Bethesda, MD. letzter Zugriff Juni 2010.
Andre, M.P., Reman, O., Federico, M., Brice, P., Brusamolino, E., Girinski, T., Ferme, C., Maazen, R.v., Bellei,
M., Sebban, C., Morschhauser, F., Lugtenburg, E., Stamatoullas, A., Baila, L., Fortpied, C., Meignan, M., and
Raemaekers, J.M. (2009). First Report On the H10 EORTC/GELA/IIL Randomized Intergroup Trial On Early
FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients with
Supra-Diaphragmatic Stage I/II Hodgkin's Lymphoma, for the Groupe d'Etude Des Lymphomes De l'Adulte
(GELA), European Organisation for the Research and Treatment of Cancer (EORTC) Lymphoma Group and the
Intergruppo Italiano Linfomi (IIL) [Abstract]. Blood 114, 97.
121